AI assistant
Sending…
Bionano Genomics, Inc. — Director's Dealing 2018
Aug 21, 2018
35041_dirs_2018-08-21_cc4cc5be-fc01-4990-a560-b7cdee0ee93a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21
Reporting Person: Cai Darren (Director)
More from Bionano Genomics, Inc.
Capital/Financing Update
2026
May 28
Declaration of Voting Results & Voting Rights Announcements
2026
May 14
Earnings Release
2026
May 13
Capital/Financing Update
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 2
Share Issue/Capital Change
2026
Mar 25
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18